Possible role for sentinal node biopsy in the management of squamous cell carcinomas in inherited epidermolysis bullosa

Archives of Dermatology

Volumn 140, Issue 8, 2004, Pages 1012-1013

  Fine, Jo David ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOSURGERY; EPIDERMOLYSIS BULLOSA; HIGH RISK PATIENT; HUMAN; METASTASIS; NOTE; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; SURVIVAL;

EID: 4043170004     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.8.1012-b     Document Type: Note

References (2)

1. Wagner JD, Evdokimow DZ, Weisberger E, et al. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol. 2004;140:75-79.
2. Fine JD, Johnson LB, Suchindran C, et al. Cancer and inherited epidermolysis bullosa: lifetable analyses of the National Epidermolysis Bullosa Registry study population. In: Fine JD, Bauer EA, McGuire J, Moshell A, eds. Epidermolysis Bullosa: Clinical, Epidemiologic, and Laboratory Advances, and the Findings of the National Epidermolysis Bullosa Registry. Baltimore, Md: Johns Hopkins University Press; 1999:175-192.